Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction

Exercise oscillatory ventilation (EOV) is a pivotal cardiopulmonary exercise test parameter for the prognostic evaluation of patients with chronic heart failure (HF). It has been described in patients with HF with reduced ejection fraction (<40%, HFrEF) and with HF with preserved ejection fraction (>50%, HFpEF), but no data are available for patients with HF with mid‐range ejection fraction (40–49%, HFmrEF). The aim of the study was to evaluate the prognostic role of EOV in HFmrEF patients.

[1]  P. Agostoni,et al.  How to perform and report a cardiopulmonary exercise test in patients with chronic heart failure. , 2019, International journal of cardiology.

[2]  M. Gnemmi,et al.  Prevalence of exertional oscillatory ventilation in continuous-flow left ventricular assist device recipients , 2018, European journal of preventive cardiology.

[3]  T. Takken,et al.  The Role of Gas Exchange Variables in Cardiopulmonary Exercise Testing for Risk Stratification and Management of Heart Failure with Reduced Ejection Fraction , 2018, American heart journal.

[4]  R. Arena,et al.  A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid‐range, and preserved ejection fraction , 2018, European journal of heart failure.

[5]  Sanjiv J. Shah,et al.  Predictors and outcomes of heart failure with mid‐range ejection fraction , 2018, European journal of heart failure.

[6]  G. Parati,et al.  Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long‐term comparison , 2017, European journal of heart failure.

[7]  S. Keteyian,et al.  Exercise Oscillatory Ventilation: Interreviewer Agreement and a Novel Determination , 2017, Medicine and science in sports and exercise.

[8]  M. Pfisterer,et al.  Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF) , 2017, European journal of heart failure.

[9]  Roland A Matsouaka,et al.  Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.

[10]  G. Fonarow,et al.  Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. , 2017, JACC. Heart failure.

[11]  Y. Takeishi,et al.  Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction , 2017, European journal of preventive cardiology.

[12]  A. Shah,et al.  Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction , 2017, Journal of the American Heart Association.

[13]  T. Shiroto,et al.  Characterization of heart failure patients with mid‐range left ventricular ejection fraction—a report from the CHART‐2 Study , 2017, European journal of heart failure.

[14]  A. Ventosa,et al.  Comparative Analysis of Four Scores to Stratify Patients With Heart Failure and Reduced Ejection Fraction. , 2017, The American journal of cardiology.

[15]  Michele Emdin,et al.  Periodic Breathing during Incremental Exercise , 2017, Annals of the American Thoracic Society.

[16]  G. Parati,et al.  Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database , 2017, European journal of heart failure.

[17]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[18]  G. Parati,et al.  Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias. , 2016, The Canadian journal of cardiology.

[19]  C. Lam,et al.  Understanding Heart Failure With Mid-Range Ejection Fraction. , 2016, JACC. Heart failure.

[20]  S. Keteyian,et al.  Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project. , 2016, American heart journal.

[21]  G. Lewis,et al.  Exercise oscillatory ventilation: Mechanisms and prognostic significance. , 2016, World journal of cardiology.

[22]  R. Arena,et al.  Prevalence and characterization of exercise oscillatory ventilation in apparently healthy individuals at variable risk for cardiovascular disease: A subanalysis of the EURO-EX trial , 2016, European journal of preventive cardiology.

[23]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[24]  C. Vrints,et al.  An overview of the applied definitions and diagnostic methods to assess exercise oscillatory ventilation--a systematic review. , 2015, International journal of cardiology.

[25]  M. Piepoli,et al.  Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure. , 2015, International journal of cardiology.

[26]  G. Parati,et al.  Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[27]  C. Vrints,et al.  Prognostic respiratory parameters in heart failure patients with and without exercise oscillatory ventilation - a systematic review and descriptive meta-analysis. , 2015, International journal of cardiology.

[28]  Deepak L. Bhatt,et al.  Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. , 2014, American heart journal.

[29]  Jeffrey M. Turner,et al.  Loop Diuretic Efficiency: A Metric of Diuretic Responsiveness With Prognostic Importance in Acute Decompensated Heart Failure , 2014, Circulation. Heart failure.

[30]  G. Parati,et al.  Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. , 2013, International journal of cardiology.

[31]  G. Parati,et al.  Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. , 2013, International journal of cardiology.

[32]  Luc Vanhees,et al.  Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations , 2012, Circulation.

[33]  C. Ronco,et al.  Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. , 2012, Journal of the American College of Cardiology.

[34]  Ross Arena,et al.  Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. , 2010, Circulation.

[35]  James E. Hansen,et al.  Oscillatory breathing and exercise gas exchange abnormalities prognosticate early mortality and morbidity in heart failure. , 2010, Journal of the American College of Cardiology.

[36]  J. Cleland,et al.  Impact of different diagnostic criteria on the prevalence and prognostic significance of exertional oscillatory ventilation in patients with chronic heart failure , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[37]  P. Agostoni,et al.  Influence of exertional oscillatory ventilation on exercise performance in heart failure , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[38]  D. Bensimhon,et al.  Exercise oscillatory breathing in diastolic heart failure: prevalence and prognostic insights. , 2008, European heart journal.

[39]  R. Arena,et al.  The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review , 2008, Heart Failure Reviews.

[40]  Nancy M Albert,et al.  Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.

[41]  A. Mansur,et al.  Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. , 2003, Journal of the American College of Cardiology.

[42]  V. Somers,et al.  Central Sleep Apnea in Left Ventricular Dysfunction: Prevalence and Implications for Arrhythmic Risk , 2003, Circulation.

[43]  Andrea Giordano,et al.  Oscillatory ventilation during exercise in patients with chronic heart failure: clinical correlates and prognostic implications. , 2002, Chest.

[44]  M. Piepoli,et al.  Quantitative General Theory for Periodic Breathing in Chronic Heart Failure and its Clinical Implications , 2000, Circulation.

[45]  M. Khoo,et al.  Determinants of ventilatory instability and variability. , 2000, Respiration physiology.

[46]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[47]  R. Casaburi,et al.  Evidence that circulatory oscillations accompany ventilatory oscillations during exercise in patients with heart failure. , 1992, The American review of respiratory disease.

[48]  J. Ribeiro,et al.  Periodic breathing during exercise in severe heart failure. Reversal with milrinone or cardiac transplantation. , 1987, Chest.

[49]  J. E. Hansen,et al.  Predicted values for clinical exercise testing. , 2015, The American review of respiratory disease.